Adjuvant Holdings Co.,Ltd. (TYO:4929)

Revenue by Segment

Financials in millions JPY. Fiscal year is April - March.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Mar 20, 2026	Mar 20, 2025	Mar 20, 2024	Mar 20, 2023	Mar 20, 2022	Mar 20, 2021	Mar 20, 2020	Mar 20, 2019	Mar 20, 2018	Mar 20, 2017
Planning, Research and Development, Sales and Related Services for Cosmetics	3.81B	4.10B	4.44B	4.38B	4.43B
Total	3.81B	4.10B	4.44B	4.38B	4.43B

Revenue by Geography

Financials in millions JPY. Fiscal year is April - March.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Mar 20, 2026	Mar 20, 2025	Mar 20, 2024	Mar 20, 2023	Mar 20, 2022	Mar 20, 2021	Mar 20, 2020	Mar 20, 2019	Mar 20, 2018	Mar 20, 2017
Japan	3.65B	3.95B	4.19B	4.16B	4.23B
Overseas	158.00M	149.00M	246.00M	212.00M	199.00M
Total	3.81B	4.10B	4.44B	4.38B	4.43B

Data Source: S&P Global Market Intelligence Last updated: Oct 21, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 6, 2026

Data Sources Report a data error